Establishing a Human Renal Cell Carcinoma Tumorgraft Platform for Preclinical Drug Testing

od Pavía-Jiménez, Andrea, Tcheuyap, Vanina Toffessi, Brugarolas, James
Wydane w Nat Protoc (2014)

Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome

od Denard, Bray, Pavia-Jimenez, Andrea, Chen, Weina, Williams, Noelle S., Naina, Harris, Collins, Robert, Brugarolas, James, Ye, Jin
Wydane w PLoS One (2015)

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal cell carcinoma: a retrospective analysis with independent validation

od Kapur, Payal, Peña-Llopis, Samuel, Christie, Alana, Zhrebker, Leah, Pavía-Jiménez, Andrea, Rathmell, W. Kimryn, Xie, Xian-Jin, Brugarolas, James
Wydane w Lancet Oncol (2013)

High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma

od Wolff, Nicholas C., Pavía-Jiménez, Andrea, Tcheuyap, Vanina T., Alexander, Shane, Vishwanath, Mridula, Christie, Alana, Xie, Xian-Jin, Williams, Noelle S., Kapur, Payal, Posner, Bruce, McKay, Renée M., Brugarolas, James
Wydane w Oncotarget (2015)

Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma

od Tran, Tram Anh, Leong, Hon Sing, Pavia-Jimenez, Andrea, Fedyshyn, Slavic, Yang, Juan, Kucejova, Blanka, Sivanand, Sharanya, Spence, Patrick, Xie, Xian-Jin, Peña-Llopis, Samuel, Power, Nicholas, Brugarolas, James
Wydane w Mol Cell Biol (2016)

A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma

od Farley, Megan N., Schmidt, Laura S., Mester, Jessica L., Pena-Llopis, Samuel, Pavia-Jimenez, Andrea, Christie, Alana, Vocke, Cathy D., Ricketts, Christopher J., Peterson, James, Middelton, Lindsay, Kinch, Lisa, Grishin, Nick, Merino, Maria J., Metwalli, Adam R., Xing, Chao, Xie, Xian-Jin, Dahia, Patricia L.M., Eng, Charis, Linehan, W. Marston, Brugarolas, James
Wydane 2013

A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma

od Sivanand, Sharanya, Peña-Llopis, Samuel, Zhao, Hong, Kucejova, Blanka, Spence, Patrick, Pavia-Jimenez, Andrea, Yamasaki, Toshinari, McBride, David J., Gillen, Jessica, Wolff, Nicholas C., Morlock, Lorraine, Lotan, Yair, Raj, Ganesh V., Sagalowsky, Arthur, Margulis, Vitaly, Cadeddu, Jeffrey A., Ross, Mark T., Bentley, David R., Kabbani, Wareef, Xie, Xian-Jin, Kapur, Payal, Williams, Noelle S., Brugarolas, James
Wydane 2012

BAP1 loss defines a new class of renal cell carcinoma

od Peña-Llopis, Samuel, Vega-Rubín-de-Celis, Silvia, Liao, Arnold, Leng, Nan, Pavía-Jiménez, Andrea, Wang, Shanshan, Yamasaki, Toshinari, Zhrebker, Leah, Sivanand, Sharanya, Spence, Patrick, Kinch, Lisa, Hambuch, Tina, Jain, Suneer, Lotan, Yair, Margulis, Vitaly, Sagalowsky, Arthur I., Summerour, Pia Banerji, Kabbani, Wareef, Wong, S. W. Wendy, Grishin, Nick, Laurent, Marc, Xie, Xian-Jin, Haudenschild, Christian D., Ross, Mark T., Bentley, David R., Kapur, Payal, Brugarolas, James
Wydane 2012

Addressing metabolic heterogeneity in clear cell renal cell carcinoma with quantitative Dixon MRI

od Zhang, Yue, Udayakumar, Durga, Cai, Ling, Hu, Zeping, Kapur, Payal, Kho, Eun-Young, Pavía-Jiménez, Andrea, Fulkerson, Michael, de Leon, Alberto Diaz, Yuan, Qing, Dimitrov, Ivan E., Yokoo, Takeshi, Ye, Jin, Mitsche, Matthew A., Kim, Hyeonwoo, McDonald, Jeffrey G., Xi, Yin, Madhuranthakam, Ananth J., Dwivedi, Durgesh K., Lenkinski, Robert E., Cadeddu, Jeffrey A., Margulis, Vitaly, Brugarolas, James, DeBerardinis, Ralph J., Pedrosa, Ivan
Wydane w JCI Insight (2017)

Targeting Renal Cell Carcinoma with a HIF-2 antagonist

od Chen, Wenfang, Hill, Haley, Christie, Alana, Kim, Min Soo, Holloman, Eboni, Pavia-Jimenez, Andrea, Homayoun, Farrah, Ma, Yuanqing, Patel, Nirav, Yell, Paul, Hao, Guiyang, Yousuf, Qurratulain, Joyce, Allison, Pedrosa, Ivan, Geiger, Heather, Zhang, He, Chang, Jenny, Gardner, Kevin H., Bruick, Richard K., Reeves, Catherine, Hwang, Tae Hyun, Courtney, Kevin, Frenkel, Eugene, Sun, Xiankai, Zojwalla, Naseem, Wong, Tai, Rizzi, James P., Wallace, Eli M., Josey, John A., Xie, Yang, Xie, Xian-Jin, Kapur, Payal, McKay, Renée M., Brugarolas, James
Wydane w Nature (2016)

Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes

od Durinck, Steffen, Stawiski, Eric W, Pavía-Jiménez, Andrea, Modrusan, Zora, Kapur, Payal, Jaiswal, Bijay S, Zhang, Na, Toffessi-Tcheuyap, Vanina, Nguyen, Thong T, Pahuja, Kanika Bajaj, Chen, Ying-Jiun, Saleem, Sadia, Chaudhuri, Subhra, Heldens, Sherry, Jackson, Marlena, Peña-Llopis, Samuel, Guillory, Joseph, Toy, Karen, Ha, Connie, Harris, Corissa J, Holloman, Eboni, Hill, Haley M, Stinson, Jeremy, Rivers, Celina Sanchez, Janakiraman, Vasantharajan, Wang, Weiru, Kinch, Lisa N, Grishin, Nick V, Haverty, Peter M, Chow, Bernard, Gehring, Julian S, Reeder, Jens, Pau, Gregoire, Wu, Thomas D, Margulis, Vitaly, Lotan, Yair, Sagalowsky, Arthur, Pedrosa, Ivan, de Sauvage, Frederic J, Brugarolas, James, Seshagiri, Somasekar
Wydane w Nat Genet (2014)